Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
医学博士, 東京大学
External positions
Professor, School of Medicine, Teikyo University
Apr 2024 → …
Associate Professor, School of Medicine, Teikyo University
Apr 2019 → Mar 2024
Lecturer, School of Medicine, Teikyo University
Jul 2017 → Mar 2019
Lecturer, Second Department of Medicine, The University of Tokyo
Feb 2016 → Jun 2017
Assistant Professor, The University of Tokyo Hospital
Oct 2015 → Jan 2016
Research Associate, The University of Tokyo Hospital
Apr 2013 → Sep 2015
Assistant professor, The University of Tokyo Hospital
Apr 2012 → Mar 2013
Graduate Student, The University of Tokyo Hospital
Apr 2008 → Mar 2012
常勤医, The University of Tokyo Hospital
Dec 2006 → Mar 2008
Senior resident, The University of Tokyo Hospital
Apr 2006 → Nov 2006
Resident, The University of Tokyo Hospital
Apr 2004 → Mar 2006
Student, The University of Tokyo
Apr 1998 → Mar 2004
Keywords
- Atopic dermatitis
- Psoriasis
- Autoimmune blistering disease
Research Fields
- Dermatology
Fingerprint
Dive into the research topics where MASAHIRO KAMATA is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform Dermatitis
Shimizu, T., Kamata, M., Uratsuji, H., Okada, Y., Watanabe, A., Hiura, A., Tomura, Y. & Tada, Y., Jan 2026, In: Journal of Dermatology. 53, 1, p. 25-34 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Blood DNA virome associates with autoimmune diseases and COVID-19
Japan COVID-19 Task Force, Jan 2025, In: Nature Genetics. 57, 1, p. 65-79 15 p., e20191766.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study
Watanabe, A., Kamata, M., Okada, Y., Suzuki, S., Chijiwa, C., Tomura, Y., Hiura, A., Hayashi, K., Tanaka, T. & Tada, Y., 2025, (Accepted/In press) In: Journal of Dermatology.Research output: Contribution to journal › Letter › peer-review
-
Correction to: Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis (American Journal of Clinical Dermatology, (2025), 26, 3, (411-424), 10.1007/s40257-025-00927-x)
Rønnstad, A. T. M., Bunick, C. G., Chovatiya, R., Kamata, M., Nielsen, M. L., Isufi, D., Thomsen, S. F., Vestergaard, C., Wollenberg, A., Egeberg, A., Thyssen, J. P. & Loft, N., Jul 2025, In: American Journal of Clinical Dermatology. 26, 4, p. 639 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
Kamata, M., Sun, D. I. & Paller, A. S., Aug 2025, In: Journal of Allergy and Clinical Immunology: In Practice. 13, 8, p. 1901-1910.e1Research output: Contribution to journal › Article › peer-review
7 Scopus citations